BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugiura M, Naganawa S, Sone M, Yoshida T, Nakashima T. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in a patient with cochlear otosclerosis. Auris Nasus Larynx 2008;35:269-72. [PMID: 17804186 DOI: 10.1016/j.anl.2007.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mukaida T, Sone M, Yoshida T, Kato K, Teranishi M, Naganawa S, Nakashima T. Magnetic Resonance Imaging Evaluation of Endolymphatic Hydrops in Cases With Otosclerosis. Otology & Neurotology 2015;36:1146-50. [DOI: 10.1097/mao.0000000000000685] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
2 Lee IH, Kim HJ, Chung WH, Kim E, Moon JW, Kim ST, Kim KH, Jeon P, Byun HS. Signal intensity change of the labyrinth in patients with surgically confirmed or radiologically diagnosed vestibular schwannoma on isotropic 3D fluid-attenuated inversion recovery MR imaging at 3 T. Eur Radiol 2010;20:949-57. [PMID: 19898851 DOI: 10.1007/s00330-009-1626-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
3 Eliezer M, Poillon G, Maquet C, Gillibert A, Horion J, Marie JP, Guichard JP, Magne N, Attyé A. Sensorineural hearing loss in patients with vestibular schwannoma correlates with the presence of utricular hydrops as diagnosed on heavily T2-weighted MRI. Diagn Interv Imaging 2019;100:259-68. [PMID: 30773403 DOI: 10.1016/j.diii.2019.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
4 Virk JS, Singh A, Lingam RK. The role of imaging in the diagnosis and management of otosclerosis. Otol Neurotol 2013;34:e55-60. [PMID: 23921926 DOI: 10.1097/MAO.0b013e318298ac96] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 3.1] [Reference Citation Analysis]
5 Tanigawa T, Tanaka H, Sato T, Nakao Y, Katahira N, Tsuchiya Y, Nonoyama H, Ueda H. 3D-FLAIR MRI findings in patients with low-tone sudden deafness. Acta Oto-Laryngologica 2010;130:1324-8. [DOI: 10.3109/00016489.2010.496461] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
6 Berrettini S, Ravecca F, Volterrani D, Neri E, Forli F. Imaging Evaluation in Otosclerosis: Single Photon Emission Computed Tomography and Computed Tomography. Ann Otol Rhinol Laryngol 2010;119:215-24. [DOI: 10.1177/000348941011900402] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
7 Berrettini S, Lombardo F, Bruschini L, Ciabotti A, Raffaello C, De Cori Sara, De Marchi Daniele, Forli F. 3D fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging at different stages of otosclerosis. Eur Arch Otorhinolaryngol 2018;275:2643-52. [PMID: 30191304 DOI: 10.1007/s00405-018-5093-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nakata S, Mizuno T, Naganawa S, Sugiura M, Yoshida T, Teranishi M, Sone M, Nakashima T. 3D-FLAIR MRI in facial nerve paralysis with and without audio-vestibular disorder. Acta Otolaryngol 2010;130:632-6. [PMID: 19916898 DOI: 10.3109/00016480903338123] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
9 Miller ME, Mafee MF, Bykowski J, Alexander TH, Burchette RJ, Mastrodimos B, Cueva RA. Hearing Preservation and Vestibular Schwannoma: Intracochlear FLAIR Signal Relates to Hearing Level. Otology & Neurotology 2014;35:348-52. [DOI: 10.1097/mao.0000000000000191] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
10 Yamazaki M, Naganawa S, Tagaya M, Kawai H, Ikeda M, Sone M, Teranishi M, Suzuki H, Nakashima T. Comparison of contrast effect on the cochlear perilymph after intratympanic and intravenous gadolinium injection. AJNR Am J Neuroradiol. 2012;33:773-778. [PMID: 22173762 DOI: 10.3174/ajnr.a2821] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kim DY, Lee JH, Goh MJ, Sung YS, Choi YJ, Yoon RG, Cho SH, Ahn JH, Park HJ, Baek JH. Clinical significance of an increased cochlear 3D fluid-attenuated inversion recovery signal intensity on an MR imaging examination in patients with acoustic neuroma. AJNR Am J Neuroradiol 2014;35:1825-9. [PMID: 24742808 DOI: 10.3174/ajnr.A3936] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
12 Naganawa S, Kawai H, Taoka T, Suzuki K, Iwano S, Satake H, Sone M, Ikeda M. Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide. Magn Reson Med Sci 2016;15:308-15. [PMID: 26841857 DOI: 10.2463/mrms.mp.2015-0121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
13 Yamazaki M, Naganawa S, Kawai H, Nihashi T, Fukatsu H, Nakashima T. Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009;51:855-63. [PMID: 19727694 DOI: 10.1007/s00234-009-0588-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
14 Lombardo F, De Cori S, Aghakhanyan G, Montanaro D, De Marchi D, Frijia F, Fortunato S, Forli F, Chiappino D, Berrettini S, Canapicchi R. 3D-Flair sequence at 3T in cochlear otosclerosis. Eur Radiol 2016;26:3744-51. [PMID: 26747254 DOI: 10.1007/s00330-015-4170-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim TY, Park DW, Lee YJ, Lee JY, Lee SH, Chung JH, Lee S. Comparison of Inner Ear Contrast Enhancement among Patients with Unilateral Inner Ear Symptoms in MR Images Obtained 10 Minutes and 4 Hours after Gadolinium Injection. AJNR Am J Neuroradiol 2015;36:2367-72. [PMID: 26316569 DOI: 10.3174/ajnr.A4439] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]